All In Biotech

Drug Trial Radar · NCT05848947

SIR-Spheres Study to Calculate the Radiation-Absorbed Dose of 99mTc-MAA

Study to Calculate the Radiation-Absorbed Dose of Technetium-99m Macroaggregated Albumin (99mTc-MAA) to the Whole Body and Non-Liver Critical Organs

Last checked: Nov 20, 2026Latest source record: Jan 29, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

5

Actual

Start

Apr 25, 2023

Primary completion

Jul 5, 2023

Study completion Jul 5, 2023

Sponsor

Lead sponsor
Sirtex MedicalIndustry
Sponsor type
Industry
Collaborators
Bright Research Partners
First posted
May 8, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Other
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this interventional clinical trial is to evaluate the dose of radiation of Technetium-99m macroaggregated-albumin (99mTc-MAA) after an intra-arterial injection to the whole body and non-liver critical organs in patients who are undergoing evaluation for SIR-Spheres treatment for hepatocellular carcinoma.

Conditions

  • Carcinoma
  • Carcinoma, Hepatocellular
  • Liver Neoplasm

Interventions

  • 99mTc-Macro Albumin AggregateDrug

    Technetium-99m macroaggregated-albumin consists of macroaggregated-albumin particles labeled with technetium-99m (99mTc), with a size between 10 and 90 microns in diameter. 99mTc is a gamma emitting radioactive isotope commonly used for diagnostic localization studies.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean Absorbed Dose (Gy) for the Whole BodyTime frame: 18-24 hours
  2. Mean Absorbed Dose (Gy) for Critical Non-liver OrgansTime frame: 18-24 hours
  3. Mean Activity (Bq) for the Whole BodyTime frame: 18-24 hours
  4. Mean Activity (Bq) for Critical Non-liver OrgansTime frame: 18-24 hours
  5. Effective Dose (Gy) for the Whole BodyTime frame: 18-24 hours

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Inland Imaging

    Spokane, Washington

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.